HCA
BVS icon

Harbor Capital Advisors’s Bioventus BVS Stock Holding History

Harbor Capital Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Buy
28,093
+2,088
+8% +$19.9K 0.02% 598
2026
Q1 		$237K Buy
26,005
+6,503
+33% +$54.5K 0.02% 579
2025
Q4 		$145K Buy
19,502
+690
+4% +$4.96K 0.01% 659
2025
Q3 		$126K Sell
18,812
-5,670
-23% -$39.3K 0.01% 647
2025
Q2 		$162K Buy
24,482
+2,615
+12% +$18.5K 0.01% 624
2025
Q1 		$200K Buy
+21,867
New +$218K 0.01% 616

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Harbor Capital Advisors's BVS Position: Q2 2026 in Review

Harbor Capital Advisors increased its Bioventus (BVS) stake by 8% in Q2 2026, buying an estimated $19.9K and bringing the position to 28,093 shares worth $265K. The position accounts for 0.02% of the portfolio, ranked #598.

Harbor Capital Advisors first reported a position in BVS in Q1 2025 and has held it in 6 quarters since. 67 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Harbor Capital Advisors held 28,093 shares of Bioventus worth $265K as of Q2 2026.
  • Harbor Capital Advisors bought 2,088 Bioventus shares in Q2 2026, an estimated $19.9K.
  • Bioventus made up 0.02% of Harbor Capital Advisors's portfolio in Q2 2026, its #598 holding.
  • Harbor Capital Advisors first reported a position in Bioventus in Q1 2025 and has held it in 6 quarters since.
  • 67 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.